Saturday, July 25, 2026

pharma · Melanoma · Tumor · NKTR

Nektar Therapeutics UK

Nektar Therapeutics UK trial registry — 3 ClinicalTrials.gov studies with program phase, status, and indication context.

455 Mission Bay Boulevard South, San Francisco, California 94158, US HQ
1990 Founded
610 Employees
Public company Type
NKTR · NYSE Ticker
Company details
Status
Public
HQ
455 Mission Bay Boulevard South, San Francisco, California 94158, US
Founded
1990
Employees
610
Programs
3
Drugs
17
Patents
2
Intelligence · Clinical Trials

Nektar Therapeutics UK clinical trials

Registry index of 3 ClinicalTrials.gov studies linked to Nektar Therapeutics UK programs — each row shows trial ID, program name, phase, status, and indication.

Nektar Therapeutics UK trial registry — 3 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

3 updates

Latest clinical program signals indexed for Nektar Therapeutics UK.

  1. NKTR-102 q14d — Phase 2

    Clinical update
  2. NKTR-102 100 mg/m2 — Phase 2

    Clinical update
  3. Nivolumab — Phase 2

    Clinical update

Trial registry

3 studies